NCT04072861View on ClinicalTrials.gov

A Study of RBT-9 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2019

Primary Completion Date

July 31, 2020

Study Completion Date

October 31, 2020

Conditions
Healthy VolunteersChronic Kidney Disease
Interventions
DRUG

RBT-9

intravenous administration

Trial Locations (1)

32132

Riverside Clinical Research, Edgewater

All Listed Sponsors
lead

Renibus Therapeutics, Inc.

INDUSTRY

NCT04072861 - A Study of RBT-9 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease | Biotech Hunter | Biotech Hunter